SMOFlipid clinical trials
Also written Medium chain triglycerides.
How each study uses SMOFlipid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the SMOFlipid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 13 Jul 2016 · SMOFLIPID 20% · NDA 207648 (FDA, Drugs@FDA; in a combination)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
33 studies that test it; most in 2017 (4)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 28
Fresenius Kabi (4) · University of Florida (2) · Mayo Clinic (2) · Assiut University (2) · Mansoura University (2) · Coordinación de Investigación en Salud, Mexico (1) · Indiana University (1) · Alexandria University (1)
Often tested with
Tested in the same studies.
Soybean oil, phospholipid emulsion (4) · ClinOleic (1) · Fish oil triglycerides (1) · Fish Oils (1) · MCT/LCT/Fish Oil Omega-3 Fatty Acid Lipid Emulsion (1) · Lipofundin (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test SMOFlipid.
- Nov 2026Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsPhase 4 · Fresenius Kabi
Studies
Open first, then newest update. How each study uses SMOFlipid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 33
- Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsRecruitingPhase 4Fresenius KabiNCT06049680Written as SMOFlipid® (lipid injectable emulsion)
- Comparison of Intralipid With SMOF Lipid Following HSCTRecruitingNot applicableShahid Beheshti UniversityNCT06625372Written as SMOF lipid
- Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDHActive, not recruitingPhase 2Coordinación de Investigación en Salud, MexicoNCT04031508Written as lipid injectable emulsion with Fish oil
- LIPIDS-P Trial Phase I/II TrialCompletedPhase 1/2University of FloridaNCT03405870Written as Smoflipid
- Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical NeonatesCompletedPhase 3Indiana UniversityNCT03387579Written as Smoflipid 20% Lipid Emulsion for Injection
- Intralipid Versus SMOFlipid in HPN PatientsCompletedNot applicableMayo ClinicNCT03773237Written as SMOFLipid
- Efficacy of SMOF Lipid in the Management of Acute Poisoning With CarbamazepineCompletedPhase 2Alexandria UniversityNCT06316362Written as SMOF lipid 20%
- Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of AgeTerminatedPhase 4Fresenius KabiNCT03563222Written as Smoflipid
- Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and InfantsTerminatedPhase 3Fresenius KabiNCT02579265Written as Smoflipid 20% (investigational lipid for parenteral nutrition)
- Lipid Emulsion Infusion and COVID-19 PatientsCompletedPhase 3Assiut UniversityNCT04957940Written as SMOFlipid
- Lipid Emulsion in Cardiac Valve Replacement SurgeryStatus unknownNot applicableAssiut UniversityNCT04951791Written as SMOFlipid
- Market Research - Acceptability Study for New MCT Fat ProductsCompletedNot applicableDr. Schär AG / SPANCT04309214Written as MCT fats
- Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature InfantsStatus unknownPhase 4Shanghai Jiao Tong University School of MedicineNCT04277923Written as SMOFlipid
- MiCrobiome dieT StudyCompletedNot applicableUniversity of MinnesotaNCT03610477Written as Medium chain triglycerides
- Rate of Bronchopulmonary Dysplasia in Preterms Neonates: a Trial Comparing SMOFlipid and MedialipideWithdrawnPhase 4Hospices Civils de LyonNCT02853253Written as SMOFlipid®
- Evaluation of Medium Chain Triglycerides in a Mixed Racial Population of Patients: a Feasibility StudyCompletedNot applicableBoston Medical CenterNCT02783703Written as Medium chain triglycerides (MCT)
- The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With SepsisCompletedPhase 4Mansoura University Children HospitalNCT03275090Written as Smoflipid ®
- SMOFLipid in Patients Who Are Intralipid IntolerantWithdrawnPhase 4Mayo ClinicNCT03054948Written as SMOFLipid
- Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.CompletedNot applicableYale UniversityNCT01315171Written as Medium chain triglycerides
- Preventing Cholestasis Using SMOFLipid®CompletedPhase 4Medical University of ViennaNCT01585935Written as SMOFLIPID
See all 33 studies that test SMOFlipid →
Given beside what is tested · 1 — SMOFlipid is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with SMOFlipid
Codes
What other systems call SMOFlipid · ClinicalTrials.gg INT001400
- MeSH (NLM) C000709826SMOFlipidConfirmed ClinicalTrials.gov, NLM
- RxNorm 1310578One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000709826 | SMOFlipid | Confirmed ClinicalTrials.gov, NLM |
| RxNorm | 1310578 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.